Continuous Flow Synthesis of ACE Inhibitors From N‐Substituted l‐Alanine Derivatives
- 18 October 2019
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 25 (64) , 14527-14531
Abstract
A strategy for the continuous flow synthesis of angiotensin converting enzyme (ACE) inhibitors is described. An optimization effort guided by in situ IR analysis resulted in a general amide coupling approach facilitated by N‐carboxyanhydride (NCA) activation that was further characterized by reaction kinetics analysis in batch. The three‐step continuous process was demonstrated by synthesizing 8 different ACE inhibitors in up to 88 % yield with throughputs in the range of ≈0.5 g h−1, all while avoiding both isolation of reactive intermediates and process intensive reaction conditions. The process was further developed by preparing enalapril, a World Health Organization (WHO) essential medicine, in an industrially relevant flow platform that scaled throughput to ≈1 g h−1.Keywords
Funding Information
- Defense Advanced Research Projects Agency (ARO W911NF-16-2-0023)
This publication has 28 references indexed in Scilit:
- RETRACTED: Relationship between Clinic and Ambulatory Blood-Pressure Measurements and MortalityNew England Journal of Medicine, 2018
- Initial Treatment of HypertensionNew England Journal of Medicine, 2018
- HypertensionThe Lancet, 2015
- Design, synthesis, and physicochemical properties of a novel, conformationally restricted 2,3-dihydro-1,3,4-thiadiazole-containing angiotensin converting enzyme inhibitor which is preferentially eliminated by the biliary route in ratsJournal of Medicinal Chemistry, 1991
- Angiotensin converting enzyme inhibitors: spirapril and related compoundsJournal of Medicinal Chemistry, 1989
- Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivativesJournal of Medicinal Chemistry, 1989
- Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolinesJournal of Medicinal Chemistry, 1988
- Angiotensin-converting enzyme inhibitors: importance of the amide carbonyl of mercaptoacyl amino acids for hydrogen bonding to the enzymeJournal of Medicinal Chemistry, 1982
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977